Norplant® implants and progesterone vaginal rings do not affect maternal bone turnover and density during lactation and after weaning

Human Reproduction

Volumn 14, Issue 10, 1999, Pages 2499-2505

  Diaz S ^a,c   Reyes, M V ^a   Zepeda, A ^b   Gonzalez G B ^a   Lopez, J M ^b   Campino, C ^a   Croxatto, H B ^b  

^a Institute Chilene de Medicina Reproductiva   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c Instituto Chileno de Medicina Reproductiva   (Chile)

Author keywords

Bone density; Bone metabolism; Lactation; Norplant implants; Progesterone rings

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; COPPER INTRAUTERINE DEVICE; CREATININE; ESTRADIOL; FOLLITROPIN; HYDROXYPROLINE; LEVONORGESTREL; PARATHYROID HORMONE; PHOSPHORUS; PROGESTERONE; PROLACTIN; CONTRACEPTIVE AGENT;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE TURNOVER; CALCIUM BLOOD LEVEL; CONTRACEPTION; CONTROLLED STUDY; CREATININE URINE LEVEL; ESTRADIOL BLOOD LEVEL; FEMALE; FEMUR NECK; FOLLITROPIN BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYDROXYPROLINE URINE LEVEL; INTRADERMAL DRUG ADMINISTRATION; INTRAVAGINAL DRUG ADMINISTRATION; LACTATION; LONGITUDINAL STUDY; LUMBAR SPINE; NORMAL HUMAN; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PROLACTIN BLOOD LEVEL; TIME; VAGINA RING; WEANING; ADOLESCENT; BONE REMODELING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; DRUG IMPLANT; METHODOLOGY;

ADMINISTRATION, INTRAVAGINAL; ADOLESCENT; ADULT; BONE DENSITY; BONE REMODELING; CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE; DRUG IMPLANTS; FEMALE; HUMANS; INTRAUTERINE DEVICES, COPPER; LACTATION; LEVONORGESTREL; PROGESTERONE; WEANING;

EID: 0032589513     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/14.10.2499     Document Type: Article

References (25)

1. Caird, L.E., Reid-Thomas, V., Hannan, W.J. el al. 1994 Oral progestogenonly contraception may protect against loss of bone mass in breast-feeding women. Clin. Endocrinol., 41, 39-45.
2. Campino, C., Bruggendieck, B., Pumarino, H. 1987 Desarrollo de un radioimmunoanalisis para la fraccion media de hormona paratiroidea m-PTH: comparacion con dos kits comerciales para carboxilo terminal. Revista Medica de Chile, 115, 763-767.
3. Cromer, B.A., McArdle Blair, J., Mahan, J.D. 1996 A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate Depo-Provera, levonorgestrel Norplant, or oral contraceptives. J. Pediatr., 129, 671-676.
4. Croxatto, H.B., Dîaz, S., Pavez, M. (1982) Plasma progesterone levels during long-term treatment with levonorgestrel silastic implants. Acta Endocrinol., 10,307-311.
5. Cundy, T., Evans, M., Roberts, H. (1991) Bone density in women receiving depot medroxyprogesterone acetate for contraception. Br. Med. J., 303, 13-16.
6. Dîaz, S., Miranda, P., Brandeis, A. (1991) Mechanism of action of progesterone as contraceptive for lactating women. In Seppala, M. and Hamberger, L. (eds) Frontiers in Human Reproduction. The New York Academy of Sciences, New York, NY, USA, pp. 11-21.
7. Diaz, S., Zepeda, A., Maturana, X. (1997) Fertility regulation in nursing women: IX. Contraceptive performance, duration of lactation, infant growth and bleeding patterns during use of progesterone vaginal rings, progestinonly pills, Norplant® implants and Copper T 380-A intrauterine devices. Contraception, 56, 223-232.
8. Fraser, I.S., Tiitinen, A., Affandi, B. (1998) Norplant® consensus statement and background review. Contraception, 57, 1-9.
9. Hollander, M. and Wolfe, D. (eds) (1972) Nonparametric Statistical Methods. John Wiley & Sons, New York, pp. 115-125, 131.
10. Intaraprasetrt, S., Taneepanichskul, S., Theppisai, U. and Chaturachinda, K. (1997) Bone density in women receiving Norplant® implants for contraception. J. Med. Assoc. Thai., 80, 738-741.
11. International Planned Parenthood Federation (1989) Statement on Breast Feeding, Fertility and Post-partum Contraception. Statement by the International Medical Advisory Panel, November, 1-5.
12. Kalkwarf, HJ., Specker, B.L., Bianchi, D.C. el al. (1997) The effect of calcium supplementation on bone density during lactation and after weaning. N. Engl. J. Med., 337, 523-558.
13. Löpez, J.M., Gonzalez, G., Reyes, M.V. (1996) Bone turnover and density in healthy women during breast-feeding and after weaning. Osteoporosis Int., 6, 153-159.
14. Naessen, T., Olsson, S.-V. and Gudmundson, J. (1995) Differential effects on bone density of progestogen-only methods for contraception in premenopausal women. Contraception, 52, 35-39.
15. Nelson, W.E. (ed) (1964) Textbook of Pediatrics, 8th edn. W.B. Saunders Company, Philadelphia, 42 pp.
16. Phillips, A., Hahn, D.W., Klimek, S. (1987) A comparison of the potencies and activities of progestogens used in contraceptives. Contraception, 36, 181-192.
17. Prior, J.C. (1990) Progesterone as a b'one-trophic hormone. Endocrine Rev., 1, 386-398.
18. Riggs, B.L., Peck, W.A. and Bell, N.H. (eds) (1991) Physician's Resources Manual on Osieoporosis. 2nd edn. Current Medical Directions, New York, 19 pp.
19. Sivin, I., Dîaz, S., Croxatto, H.B. (1997) Contraceptives for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the copper T 380A IUD. Contraception, 55, 225-232.
20. SAS Institute Inc. (1987) SAS/STAT Guide for Personal Computers, 6th edn. SAS Institute Inc., Cary, NC.
21. SAS/STAT Software (1991) The PHREG Procedure, Preliminary Documentation. SAS Institute Inc., Cary, NC.
22. Sowers, M. (1996) Pregnancy and lactation as risk factors for subsequent bone loss and osteoporosis. J. Bone Miner. Res., 11, 1052-1060.
23. Virutamasen, P., Wangsuphachart, S., Reinprayoon, D. (1994) Trabecular bone in long-term depot-medroxyprogesterone acetate users. Asia-Oceania, J. Obstet. Gynaecol., 20, 269-274.
24. World Health Organization (1987) Special programme of research development and research training in human reproduction. Programme for the provision of matched assay reagents for the RIA of hormones in reproductive physiology. Method Manual, llth edn. WHO, Geneva.
25. World Health Organization (1996) Improving access to quality care in family planning. Medical Eligibility Criteria for Contraceptive Use. WHO/FRH/ FPP Geneva.